Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 2, 2006, Pages 363-373

  De Arruda, Fernando F ^a   Puri, Dev R ^a   Zhung, Joanne ^a   Narayana, Ashwatha ^a   Wolden, Suzanne ^a   Hunt, Margie ^a   Stambuk, Hilda ^a   Pfister, David ^a   Kraus, Dennis ^a   Shaha, Ashok ^a   Shah, Jatin ^a   Lee, Nancy Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer; Intensity modulated radiotherapy; Oropharynx; Radiation

Indexed keywords

CHEMOTHERAPY; DISEASES; HISTOLOGY; PATIENT MONITORING; RADIATION; TUMORS;

CARCINOMA; GASTROSTOMY; INTENSITY-MODULATED RADIOTHERAPY; OROPHARYNX;

RADIOTHERAPY;

ACUTE TOXICITY; ADULT; AGED; CANCER CENTER; CANCER CONTROL; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; DOSIMETRY; ESOPHAGUS STRICTURE; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARYNX DISORDER; MALE; MUCOSA INFLAMMATION; OROPHARYNX CANCER; PAROTID GLAND DISEASE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PHARYNX DISEASE; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SURVIVAL RATE; TREATMENT PLANNING; TUMOR VOLUME; XEROSTOMIA;

EID: 30544450734     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.03.006     Document Type: Article

References (37)

1. J.T. Parsons, W.M. Mendenhall, S.P. Stringer Squamous cell carcinoma of the oropharynx Surgery, radiation therapy, or both Cancer 94 2002 2967 2980
2. G. Calais, M. Alfonsi, E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma [see comment] J Natl Cancer Inst 91 1999 2081 2086
3. F. Denis, P. Garaud, E. Bardet Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma [see comment] J Clin Oncol 22 2004 69 76
4. N. Lee, P. Xia, J.M. Quivey Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma An update of the UCSF experience Int J Radiat Oncol Biol Phys 53 2002 12 22
5. F. Claus, T. Boterberg, P. Ost Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome? Radiother Oncol 64 2002 205 208
6. B.S. Henson, M.R. Inglehart, A. Eisbruch Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy Oral Oncol 37 2001 84 93
7. K.S. Chao, N. Majhail, C.J. Huang Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma A comparison with conventional techniques Radiother Oncol 61 2001 275 280
8. A. Eisbruch, L.H. Marsh, L.A. Dawson Recurrences near base of skull after IMRT for head-and-neck cancer implications for target delineation in high neck and for parotid gland sparing Int J Radiat Oncol Biol Phys 59 2004 28 42
9. K. Huang, N. Lee, P. Xia Intensity-modulated radiotherapy in the treatment of oropharyngeal carcinoma A single institutional experience Int J Radiat Oncol Biol Phys 57 2003 S302
10. K.K. Fu, T.F. Pajak, A. Trotti A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16
11. S.V. Spirou, C.S. Chui A gradient inverse planning algorithm with dose-volume constraints Med Phys 25 1998 321 333
12. R. Mohan, G. Barest, L.J. Brewster A comprehensive three-dimensional radiation treatment planning system Int J Radiat Oncol Biol Phys 15 1988 481 495
13. S.V. Spirou, C.S. Chui Generation of arbitrary intensity profiles by dynamic jaws or multileaf collimators Med Phys 21 1994 1031 1041
14. J.D. Cox, J. Stetz, T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
15. K.S. Chao, G. Ozyigit, A.I. Blanco Intensity-modulated radiation therapy for oropharyngeal carcinoma Impact of tumor volume Int J Radiat Oncol Biol Phys 59 2004 43 50
16. J.P. Pignon, J. Bourhis, C. Domenge Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer Lancet 355 2000 949 955
17. A.S. Garden, W. Morrison, D. Rosenthal Intensity modulated radiation therapy (IMRT) for metastatic cervical adenopathy from oropharynx carcinoma [Abstract] Int J Radiat Oncol Biol Phys 60 2004 S318
18. M.B. Parliament, R.A. Scrimger, S.G. Anderson Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer Int J Radiat Oncol Biol Phys 58 2004 663 673
19. A. Lin, H.M. Kim, J.E. Terrell Quality of life after parotid-sparing IMRT for head-and-neck cancer A prospective longitudinal study Int J Radiat Oncol Biol Phys 57 2003 61 70
20. A. Eisbruch, L.A. Dawson, H.M. Kim Conformal and intensity modulated irradiation of head and neck cancer The potential for improved target irradiation, salivary gland function, and quality of life Acta Otorhinolaryngol Belg 1999 271 275
21. K.S. Chao, J.O. Deasy, J. Markman A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy Initial results Int J Radiat Oncol Biol Phys 49 2001 907 916
22. M.A. Hunt, A. Jackson, A. Narayana The relationship between parotid gland-PTV overlap and the ability to achieve dosimetric sparing of the parotid using intensity modulated radiation therapy [Abstract] Int J Radiat Oncol Biol Phys 60 2004 S178 S179
23. J. Fisher, C. Scott, C.W. Scarantino Phase III quality-of-life study results impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer - RTOG 97-09 Int J Radiat Oncol Biol Phys 56 2003 832 836
24. D.M. Brizel, T.H. Wasserman, M. Henke Phase III randomized trial of amifostine as a radioprotector in head and neck cancer [see comment]. [Erratum appears in J Clin Oncol 2000;18:4110-4111]. J Clin Oncol 18 2000 3339 3345
25. K.S. Chao, G. Ozyigit, W.L. Thorsdad Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostine Semin Oncol 30 2003 101 108
26. P.A. Johnstone, R.C. Niemtzow, R.H. Riffenburgh Acupuncture for xerostomia clinical update Cancer 94 2002 1151 1156
27. A. Eisbruch, H.M. Kim, J.E. Terrell Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 695 704
28. S. Sonis Oral mucositis in cancer therapy J Support Oncol 2 2004 3 8
29. D.J. Adelstein, Y. Li, G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer [see comment] J Clin Oncol 21 2003 92 98
30. E. Alvarez, E.G. Fey, P. Valax Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis Clin Cancer Res 9 2003 3454 3461
31. D. Antonadou, M. Pepelassi, M. Synodinou Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer Int J Radiat Oncol Biol Phys 52 2002 739 747
32. J. Bourhis, R. De Crevoisier, B. Abdulkarim A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 46 2000 1105 1108
33. S. Staar, V. Rudat, H. Stuetzer Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - results of a multicentric randomized German trial in advanced head-and-neck cancer [Erratum appears in Int J Radiat Oncol Biol Phys 2001;51:569] Int J Radiat Oncol Biol Phys 50 2001 1161 1171
34. N. Magne, P.Y. Marcy, C. Foa Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy in advanced head and neck cancer patients Eur Arch Oto-Rhino-Laryngol 258 2001 89 92
35. T. Anwander, S. Berge, T. Appel Percutaneous endoscopic gastrostomy for long-term feeding of patients with oropharyngeal tumors Nutrition Cancer 50 2004 40 45
36. T.M. Mekhail, D.J. Adelstein, L.A. Rybicki Enteral nutrition during the treatment of head and neck carcinoma Is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer 91 2001 1785 1790
37. W.T. Lee, L.M. Akst, D.J. Adelstein Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation 2004 Proceedings of the Sixth International Conference on Head and Neck Cancer, August 7-11, Washington, D.C.